Dr. Linn Elisabeth Katus, DO

Dr. Katus practices at Trustees of Columbia University in the City of New York in Fort Lee, New Jersey.

Dr. Katus' NPI, 1720379969, was assigned on April 21, 2011. Dr. Katus graduated from New York Institute of Technology College of Osteopathic Medicine - Old Westbury in 2011. Dr. Katus holds New York license 278818.

Dr. Katus' primary practice is Trustees of Columbia University in the City of New York, at 400 Kelby St, Fort Lee, NJ 07024 in Bergen County. The practice phone is (646) 317-7111.

Dr. Katus' primary practice is Trustees of Columbia University in the City of New York in Fort Lee, New Jersey. Dr. Katus is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Katus to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Katus practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Katus' primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Katus is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Katus is licensed in New York.

Dmand AI lists acute mini-stroke (TIA), parkinson's disease and restless legs syndrome among the conditions Dr. Katus treats.

CMS data shows 239 Medicare services from Dr. Katus across 4 procedure codes in 2024, for 97 Medicare patients. Medicare paid $27,520 for them. Every service was in an office.

CMS counts 97 Medicare patients who saw Dr. Katus in 2024. The largest group is 65 to 74, with 36 patients. 73% of them have high cholesterol, and 63% have high blood pressure. 25% are also on Medicaid. Their average risk score is 1.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Katus' median patient age at 43, with 50% women.

In 2024, Dr. Katus wrote 420 Medicare Part D claims for 86 patients. 89% of them were for generic drugs. CMS names the drug for 314 of them, across 11 drugs with 11 or more claims each, at $104,417 in total drug cost. In 2023, CMS named 240 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Katus for performance year 2024, reported through an alternative payment model (APM). Dr. Katus accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Katus as offering telehealth.

Dmand AI links 13 papers to Dr. Katus, published from 2013 to 2025. 2024 was the busiest year, with 2. The most frequent topics are Parkinson Disease. Dr. Katus' most frequent co-authors are Steven Joel Frucht, MD, Roy Nissim Alcalay, MD and Bhooma Rajagopalan Aravamuthan, MD.

Dmand AI links Dr. Katus to 1 clinical trial. Conditions studied include Parkinson Disease and Parkinsonian Disorders.

CMS Open Payments shows 21 general payments to Dr. Katus from 8 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 57% of the total. Alexion Pharmaceuticals, Inc. paid the most, $840.

Dr. Katus graduated from New York Institute of Technology College of Osteopathic Medicine - Old Westbury in 2011.

Dr. Katus is in network with 13 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.